US Bancorp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,000
Closed -$28.4K 4250
2022
Q4
$28.4K Sell
32,000
-9,880
-24% -$13.1K ﹤0.01% 2816
2022
Q3
$66K Buy
41,880
+4,846
+13% +$11K ﹤0.01% 2396
2022
Q2
$74K Sell
37,034
-4,776
-11% -$8.26K ﹤0.01% 2384
2022
Q1
$97K Buy
41,810
+9,941
+31% +$31K ﹤0.01% 2296
2021
Q4
$149K Buy
31,869
+6,269
+24% +$38.9K ﹤0.01% 2098
2021
Q3
$195K Sell
25,600
-240
-0.9% -$2.04K ﹤0.01% 1980
2021
Q2
$251K Buy
25,840
+2,350
+10% +$18.7K ﹤0.01% 1875
2021
Q1
$195K Buy
23,490
+5,863
+33% +$61.9K ﹤0.01% 1928
2020
Q4
$120K Buy
17,627
+581
+3% +$4.67K ﹤0.01% 2128
2020
Q3
$190K Buy
17,046
+5,392
+46% +$49.3K ﹤0.01% 1792
2020
Q2
$74K Buy
+11,654
New +$44.6K ﹤0.01% 2251

Other funds holding SRNE